Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT03523572
Title Trastuzumab Deruxtecan With Nivolumab in Advanced Breast and Urothelial Cancer
Recruitment Active, not recruiting
Gender both
Phase Phase I
Variant Requirements No
Sponsors Daiichi Sankyo, Inc.
Indications

transitional cell carcinoma

breast cancer

Therapies

Nivolumab + Trastuzumab deruxtecan

Age Groups: senior | adult
Covered Countries USA

Facility Status City State Zip Country Details
UCLA - Medical Center Santa Monica California 90404-2125 United States Details
Yale University New Haven Connecticut 06520 United States Details
University of Miami Hospital & Clinics/Sylvester Comprehensive Cancer Center Miami Florida 33136 United States Details
Norton Cancer Institute Louisville Kentucky 40202-3700 United States Details
Icahn School of Medicine at Mount Sinai New York New York 10029-6504 United States Details
Levine Cancer Institute Carolinas Healthcare System Charlotte North Carolina 28204 United States Details
Gabrail Cancer Center Research Canton Ohio 44718-2566 United States Details
Tennessee Oncology - Sara Cannon Research Institute Nashville Tennessee 37203-1619 United States Details
Huntsman Cancer Institute Salt Lake City Utah 84112 United States Details
University of Washington Medical Center Seattle Washington 98109 United States Details
AZ Groeninge Kortrijk West-Vlaanderen 8500 Belgium Details
Cliniques Universitaires Saint-Luc Brussels 1200 Belgium Details
GZA Hospital Campus Sint-Augustinus Wilrijk 2610 Belgium Details
Institut de Cancerologie de L'Ouest Angers 49055 France Details
Centre Georges Francois Leclerc Dijon 21079 France Details
ICO Rene Gauducheau Saint-Herblain 44805 France Details
Charite Campus Benjamin Franklin Berlin Brandenburg 12200 Germany Details
University Hospital Frankfurt Frankfurt Hessen 60590 Germany Details
University Cancer Center Dresden Sachsen 01307 Germany Details
Ospedale San Raffaele Milano 20132 Italy Details
Fondazione IRCCS Istituto Nazionale dei Tumori Milano 20133 Italy Details
Azienda Ospedaliera Universitaria Senese U.O.C. Immunoterapia Oncologica Siena 53100 Italy Details
Hospital Gregorio Maranon Madrid Spain Madrid 28007 Spain Details
MD Anderson Cancer Center Madrid Madrid 28033 Spain Details
Hospital Universitario Ramon y Cajal Madrid Madrid 28034 Spain Details
Fundacion Jimenez Diaz Madrid 28040 Spain Details
START Madrid CIOCC Madrid 28050 Spain Details
Sarah Cannon Research Institute UK London England W1G6AD United Kingdom Details
Royal Marsden Hospital (Surrey) London Borough of Sutton SM25PT United Kingdom Details
*Shaded cells indicate that there was no data available from clincialtrials.gov for the field